Evidence map›Paper›PMID 41238807›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

Voluntary salt-reduction target setting by large food companies: a scoping review and questionnaire survey.

Miwa Yamaguchi, Ikuko Kashino, Katsuyuki Miura, Nobuo Nishi, Nayu Ikeda

Abstract readScoping Review
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Voluntary salt reduction by food companies in Japan: a practical guide to target-setting and reformulation strategies.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miwa YamaguchiNational Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Ikuko KashinoNational Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Katsuyuki MiuraNCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.
Nobuo NishiGraduate School of Public Health, St Luke's International University, Tokyo, Japan.
Nayu IkedaNational Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. ikedan@nibn.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary salt reduction is essential for the prevention of hypertension. However, food companies often lack reference information for setting appropriate salt-reduction targets. This study aimed to clarify how leading food companies in high-income countries outside Japan establish salt-reduction targets for product reformulation. A scoping review was conducted using PubMed, Google Scholar, and corporate websites. A questionnaire survey was also administered via email to companies with recognized good practices from January to March 2024. The study analyzed the scope of targeted products, salt (including sodium) content criteria, and achievement years, as well as incentives and challenges related to salt reduction. A total of 24 companies and two trade associations were included in the analysis. Among the 40 identified targets, 55% were based solely on salt, while the remaining included multiple nutrients. Regarding reformulation efforts, 68% of targets specified product quantities or proportions, and 55% committed to salt reduction in 33-100% of their products. Furthermore, 65% of the targets set salt criteria by food category; 80% used company-defined salt criteria, while the remaining used government-proposed benchmarks. The median implementation term was five years, with 65% of targets set to be achieved by 2025. Environmental, social, and governance investments were recognized as key incentives. To address reformulation challenges, stepwise approaches based on stakeholder cooperation were proposed. Overall, salt-reduction targets were set within each company's feasible range, considering government policies and global trends. These findings provide a foundation for promoting company-led initiatives to reduce salt intake and contribute to hypertension prevention.

Indexed as

Diet, Sodium-RestrictedFood IndustryHypertensionSodium Chloride, DietaryHumansSurveys and QuestionnairesSodium Chloride, DietaryCorporate targetsFood industryProduct reformulationSalt reductionScoping review

Identifiers

PMID41238807
PMCPMC12960221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.